Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2025-12-28 @ 1:33 PM
Study NCT ID:
NCT05053035
Status:
TERMINATED
Last Update Posted:
2025-06-18
First Post:
2021-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
Sponsor:
Alector Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-01
First Submit QC Date:
None
Study First Post Date:
2021-09-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-29
Results First Submit QC Date:
None
Results First Post Date:
2025-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-30
Last Update Post Date:
2025-06-18
Last Update Post Date Type:
ACTUAL